A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C

Clinical trial NCT02686138 · COMPLETED

Trial details

NCT number: NCT02686138
Sponsor: Ardelyx
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Constipation Predominant Irritable Bowel Syndrome

Start date: 2015-12-01
Primary completion: 2017-08-01
Enrollment: 593

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.